Join PanCAN on Thursday, June 25, at 11 a.m. PT / 2 p.m. ET, for a webinar focused on KRAS and pancreatic cancer. Our panel ...

An AI model called REDMOD can detect extremely early, otherwise invisible signs of pancreatic cancer in routine CT scans, well before current methods or even expert radiologists can identify them. In ...

A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal ...

Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.

Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a ...

Between 2000 and 2021, there was an increased incidence of pancreatic adenocarcinoma and a decrease in the incidence of colorectal cancer seen across age groups. HealthDay News — From 2000 to 2021, ...

Daraxonrasib improved survival outcomes in advanced pancreatic cancer, offering new hope for patients with KRAS-mutant ...

Please provide your email address to receive an email when new articles are posted on . Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones. Colorectal ...

Bizengri received FDA approval for NSCLC and pancreatic adenocarcinoma with NRG1 gene fusion after prior therapy failure. The eNRGy study showed a 33% ORR in NSCLC and 40% in pancreatic adenocarcinoma ...

Pancreatic ductal adenocarcinoma remains a highly lethal malignancy, with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) representing biologically and anatomically complex ...